Medicines (MDCO) Posts Q3 Loss of $0.06
MDCO Hot Sheet
EPS Growth %: -40.0%Financial Fact:
Research and development: 32.78M
Today's EPS Names:
CMRG, LONG, IMOS, More
The Medicines Company (NASDAQ: MDCO) reports Q3 EPS of $0.06, versus the analyst estimate of ($0.05). Revenue for the quarter was $98.80 million, which compares to the estimate of $96.99 million.
You May Also Be Interested In
- UPDATE: Youku.com (YOKU) Misses Q1 EPS by 1c; Sees Q2 Sales Up 90-100% YoY
- Intuit, Inc. (INTU) Tops Q3 EPS by 3c; Narrows FY
- Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c; Guides Q3 EPS
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
